Jump to content
Help Us , We Need Your Help Read more... ×


  • Content count

  • Joined

  • Last visited

  • Days Won


im098 last won the day on October 13 2017

im098 had the most liked content!

Community Reputation

305 Excellent

Recent Profile Visitors

22 profile views
  1. MOBY QUICK Airbus’ huge Beluga XL plane nicknamed ‘the whale in the sky’ takes maiden flight One of the biggest planes in the world has taken off for the first time above Toulouse, with 10,000 people gathering to watch By Caroline McGuire, Digital Travel Editor 19th July 2018, 12:27 pm Updated: 19th July 2018, 5:54 pm THERE'S still no word on whether pigs can fly - but you aren't going mad if you spot a whale soaring past your window anytime soon. Because Airbus's Beluga XL aircraft - nicknamed the "whale in the sky" has taken off for the first time. It took off from Toulouse Airport in France this morning for its maiden flight. A crowd of more than 10,000 people, mostly employees and subcontractors of the European aircraft manufacturer, applauded as it took to the skies. Airbus staff waved flags as the Beluga prepared for its test flight. The plane has been designed to move oversized aircraft components and has an extra 30 per cent capacity on the current Beluga planes that it will replace. This new plane is six metres longer and a metre wider, which means it can carry two A350 XWB plane wings instead of one. This extra space in the "bubble section" and the new lowered cockpit - which makes space for a main deck with direct cargo loading capabilities - is what gives the plane its unique appearance. In a nod to its whale-like shape, Airbus have painted a whale's mouth and eyes on the side of the nose. The plane, which weighs 125 tonnes, can carry up to 53 tonnes in the hold for a distance of more than 2,500 miles. To power such a heavy aircraft, there are two Rolls-Royce Trent 700 Turbofan engines - costing £530 million each - both with a thrust of 316 kN.
  2. (From right) President Halimah Yacob taking a look at the book with editor-in-chief of the English/ Malay/ Tamil Media Group at SPH Warren Fernandez, National Heritage Board chief executive Chang Hwee Nee, Straits Times heritage and community correspondent Melody Zaccheus and ST Press general manager Susan Long. ST PHOTO: GAVIN FOO
  3. https://www.channelnewsasia.com/news/singapore/ava-says-ma-ling-luncheon-meat-safe-after-antibiotics-found-in-8953316 AVA says Ma Ling luncheon meat safe, after antibiotics found in Hong Kong sample SINGAPORE: The Agri-Food and Veterinary Authority of Singapore (AVA) has assured consumers here that the Ma Ling brand of luncheon meat meets local food safety standards. This follows a study by Hong Kong's consumer watchdog which found that a sample of Ma Ling premium pork luncheon meat contained residues of a veterinary drug known as sulphonamide antibiotic. If taken in large quantities in humans, it could cause reactions such as hives, rash, swollen face, mouth and tongue. However, the consumer watchdog also noted that an adult would have to consume 15kg of the meat each day to reach the limit stated under World Health Organization guidelines. Hong Kong's consumer watchdog also tested 32 other samples of luncheon meat and sausages from other brands. It found high sodium levels in the samples, and in one case, the actual sodium content was found to be 560 times higher than what was indicated on the can. In a Facebook post on Friday (Jun 16), AVA said: "So far, the test results for Ma Ling brand luncheon meat have shown that it meets our food safety standards," adding that its tests cover a wide range of chemical contaminants and microbial contaminants such as antibiotics and Salmonella. AVA also assured the public that all meat and meat products, including canned luncheon meat, are subject to inspection to make sure they meet food safety requirements and standards. Certified SAFE for consumption for peasants as long as you don't eat more than 15kg of the meat each day
  4. To cure ills with poison / Fight poison with poison 以毒攻毒
  5. 3 Companies Recall Blood Pressure Medications Over Cancer Fears http://time.com/5340730/fda-recalls-valsartan-medicine/ Some drugs used to control high blood pressure and prevent heart failure were voluntarily recalled this past week due to an impurity that could possibly lead to cancer, the U.S. Food and Drug Administration said. These products — with the active ingredient valsartan, a generic drug used to treat high blood pressure — may contain N-nitrosodimethylamine (NDMA), a possible human carcinogen. The FDA asked three companies, Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals Industries Ltd., to recall their valsartan products. Solco and Teva were also asked to recall their drugs containing valsartan/hydrochlorothiazide (HCTZ). “We have carefully assessed the valsartan-containing medications sold in the United States, and we’ve found that the valsartan sold by these specific companies does not meet our safety standards,” said Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, in a statement. “This is why we’ve asked these companies to take immediate action to protect patients.” The FDA is now looking into the potential impacts the drugs have had on patients who have already taken them, as well as how to get rid of the impurity from future batches of these products. The agency advised patients taking the products to continue to do so until they have a suitable replacement. Companies impacted by the recall have shared instructions for patients impacted by these products. The FDA also said patients should talk to their pharmacists and doctors who prescribed the medicine to discuss their next steps. Earlier this year, the European Medicines Agency announced it was reviewing medicine with an active valsartan ingredient supplied by Zhejiang Huahai Pharmaceuticals, a China-based company, for the same reason. Zhejiang Huahai Pharmaceuticals supplied the three U.S.-based pharmaceutical companies with these products, according to The New York Times. European Medicines Agency flags defect in cardiac drug Chinese-supplied valsartan provided to multiple drugmakers is linked to cancer risk https://www.irishtimes.com/news/world/europe/european-medicines-agency-flags-defect-in-cardiac-drug-1.3568336 The revelation that the valsartan problem likely dates back to changes in manufacturing processes at Zhejiang Huahai Pharmaceutical six years ago suggests many patients could potentially have been exposed to cancer risk. A common blood pressure and heart drug manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to cancer since 2012, European regulators said on Tuesday. The revelation that the problem likely dates back to changes in manufacturing processes at Zhejiang Huahai Pharmaceutical six years ago suggests many patients could potentially have been exposed to cancer risk. The European Medicines Agency (EMA) first raised the alarm over the Chinese supplied valsartan on July 5th. And it said it is working to establish how long and at to what extent patients might have been exposed to the impurity known as NDMA. NDMA, or N-nitrosodimethylamine, is classified as a probable human carcinogen. Based on results from laboratory tests, it may cause cancer with long-term use. “It is still too early to provide information on the longer term risk NDMA may have posed for patients. EMA has made this aspect of the review a priority and will update the public as soon as new information becomes available,” the agency said. EU authorities have been recalling medicines containing valsartan from Zhejiang Huahai over the past two weeks. And the agency said such medicines should no longer be available in pharmacies. The US Food and Drug Administration also took action to recall affected valsartan-containing medicines on Friday. Zhejiang Huahai has already acknowledged that there was an impurity in some of its valsartan, which it said had sales of €43 million ($50 million) in 2017. The agency said NDMA was an unexpected impurity that was not detected by routine tests carried out by Zhejiang Huahai. It added that the manufacturing changes introduced in 2012 were believed to have produced NDMA as a byproduct. Reliance on China The case shows the reliance of consumers worldwide on medicines containing active pharmaceutical ingredients made in China. Regulators have been stepping up oversight of foreign factories in recent years to try and ensure quality control of drugs made in China and India, which is another big supplier to global drug markets. But it remains a work in progress, as highlighted by the EMA’s executive director Guido Rasi. Mr Rasi wrote recently in the agency’s annual report: “We need to think globally and work strategically with partners from around the world to make best use of our inspection capacity, so that patients can rely on the quality, safety and efficacy of all medicines, no matter where they have been manufactured.” Valsartan was originally developed by Novartis and the Swiss company marketed it as Diovan. But it is now off patent and is used in a number of generic medicines supplied by various companies. In addition to tackling high blood pressure, it is also prescribed to treat heart failure. Zhejiang Huahai, which was founded in 1989 and listed on the Shanghai stock exchange in 2003, was one of the first Chinese companies to get drugs approved in the US market. It makes active ingredients for several medicines to treat heart problems, depression, allergies and HIV, according to its website. Overall, more than two-thirds of all active drug ingredients originate in China and India, industry experts estimate, with China accounting for the lion’s share. – Reuters
  6. Najib's son criticised for catching World Cup final in Moscow KUALA LUMPUR: The son of former Malaysian prime minister Najib Razak, Mr Nazifuddin Najib, has found himself mired in controversy again after he shared photos of himself at the World Cup final in Moscow on Sunday (Jul 15). The businessman posted several photos of his trip on Facebook, including one of himself at Luzhniki Stadium, where the match between France and Croatia was held. "Yeah! Finals!!! Croatia against France, which is your choice?" Nazifuddin wrote. In a second Facebook post minutes later, he shared a photo of him and former France international Christian Karembeu. The posts drew criticism from netizens, who noted that Mr Nazifuddin's jet-setting lifestyle comes amid purported struggles by his father to post bail after he was charged for his alleged involvement in the 1MDB scandal. Supporters of Najib had raised hundreds of thousands of ringgit to help him post part of his bail. In addition, Najib had said last week that after authorities froze his personal bank account, he faced difficulties paying the bills, including his daughter's medical bills. Najib's eldest daughter, Puteri Norlisa, is reported to be undergoing chemotherapy for cancer. Before his trip to Moscow, Mr Nazifuddin was spotted in Taiwan wining and dining with Taiwanese actress Celia Chang. Ms Chang reportedly denied that they were in a relationship, and said she was the one who paid for their meals. Read more at https://www.channelnewsasia.com/news/asia/najib-son-nazifuddin-najib-criticised-world-cup-moscow-10535274
  7. https://www.channelnewsasia.com/news/singapore/smrt-trains-coo-alvin-kek-demoted-bonus-forfeited-drink-driving-10535348?cid=fbcna SINGAPORE: SMRT Trains chief operation officer Alvin Kek Yoke Boon has been demoted and will have his annual bonus for the current financial year forfeited, following a drink driving conviction last month. Read more at https://www.channelnewsasia.com/news/singapore/smrt-trains-coo-alvin-kek-demoted-bonus-forfeited-drink-driving-10535348 Still there, hanging on to his IRON RICE BOWL
  8. im098

    The KFC man's legacy

  9. https://www3.nhk.or.jp/news/html/20180716/k10011535261000.html?utm_int=news_contents_news-main_004
  10. Gallic pride took an embarrassing knock ahead of France’s World Cup final match when the annual Bastille Day military parade went awry in the air and on the ground and in full view of President Emmanuel Macron. The July 14 parade is France’s chance to display its military muscle as soldiers troop down the Champs-Elysées under the gaze of the President and French fighter and reconnaissance jets thunder past overhead. But only minutes into the parade down "the world's most beautiful avenue", a glaring glitch occurred as two gendarmes involved in a complex motorbike ballet with horsemen from the Republic Guard crashed into each other within yards of Mr Macron. But presidential eyebrows were raised once more during the flypast of Alphajets from the Patrouille de France, the Gallic equivalent of Britain’s Red Arrows. In one of the most keenly-awaited moments of the display, three sets of three jets were due to to trail the colours that make up the French tricolour flag - red, white and blue. However, due to a mix-up in charging the canisters, one of the jets had been fitted with the wrong colour - red instead of blue - meaning the jets flew over with a lop-sided flag of white, red, blue and then red again.
  11. https://www.askapollo.com/physical-appointment/doctor/amritsar/gastroenterologist/dr-jagdeep-singh-arora